1 Viral Vaccines Market Overview 1.1 Product Overview and Scope of Viral Vaccines 1.2 Viral Vaccines Segment by Type 1.2.1 Global Viral Vaccines Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Attenuated Vaccine 1.2.3 Inactivated Vaccine 1.3 Viral Vaccines Segment by Application 1.3.1 Viral Vaccines Sales Comparison by Application: (2021-2027) 1.3.2 Hospital 1.3.3 Pharmaceutical Factory 1.3.4 Research Institute 1.3.5 Others 1.4 Global Viral Vaccines Market Size Estimates and Forecasts 1.4.1 Global Viral Vaccines Revenue 2016-2027 1.4.2 Global Viral Vaccines Sales 2016-2027 1.4.3 Viral Vaccines Market Size by Region: 2016 Versus 2021 Versus 2027 2 Viral Vaccines Market Competition by Manufacturers 2.1 Global Viral Vaccines Sales Market Share by Manufacturers (2016-2021) 2.2 Global Viral Vaccines Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Viral Vaccines Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Viral Vaccines Manufacturing Sites, Area Served, Product Type 2.5 Viral Vaccines Market Competitive Situation and Trends 2.5.1 Viral Vaccines Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Viral Vaccines Players Market Share by Revenue 2.5.3 Global Viral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Viral Vaccines Retrospective Market Scenario by Region 3.1 Global Viral Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Viral Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Viral Vaccines Market Facts & Figures by Country 3.3.1 North America Viral Vaccines Sales by Country 3.3.2 North America Viral Vaccines Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Viral Vaccines Market Facts & Figures by Country 3.4.1 Europe Viral Vaccines Sales by Country 3.4.2 Europe Viral Vaccines Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Viral Vaccines Market Facts & Figures by Region 3.5.1 Asia Pacific Viral Vaccines Sales by Region 3.5.2 Asia Pacific Viral Vaccines Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Viral Vaccines Market Facts & Figures by Country 3.6.1 Latin America Viral Vaccines Sales by Country 3.6.2 Latin America Viral Vaccines Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Viral Vaccines Market Facts & Figures by Country 3.7.1 Middle East and Africa Viral Vaccines Sales by Country 3.7.2 Middle East and Africa Viral Vaccines Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Viral Vaccines Historic Market Analysis by Type 4.1 Global Viral Vaccines Sales Market Share by Type (2016-2021) 4.2 Global Viral Vaccines Revenue Market Share by Type (2016-2021) 4.3 Global Viral Vaccines Price by Type (2016-2021) 5 Global Viral Vaccines Historic Market Analysis by Application 5.1 Global Viral Vaccines Sales Market Share by Application (2016-2021) 5.2 Global Viral Vaccines Revenue Market Share by Application (2016-2021) 5.3 Global Viral Vaccines Price by Application (2016-2021) 6 Key Companies Profiled 6.1 GSK 6.1.1 GSK Corporation Information 6.1.2 GSK Description and Business Overview 6.1.3 GSK Viral Vaccines Sales, Revenue and Gross Margin (2016-2021) 6.1.4 GSK Product Portfolio 6.1.5 GSK Recent Developments/Updates 6.2 Merck 6.2.1 Merck Corporation Information 6.2.2 Merck Description and Business Overview 6.2.3 Merck Viral Vaccines Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Merck Product Portfolio 6.2.5 Merck Recent Developments/Updates 6.3 Novartis 6.3.1 Novartis Corporation Information 6.3.2 Novartis Description and Business Overview 6.3.3 Novartis Viral Vaccines Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Novartis Product Portfolio 6.3.5 Novartis Recent Developments/Updates 6.4 Pfizer 6.4.1 Pfizer Corporation Information 6.4.2 Pfizer Description and Business Overview 6.4.3 Pfizer Viral Vaccines Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Pfizer Product Portfolio 6.4.5 Pfizer Recent Developments/Updates 6.5 Sanofi 6.5.1 Sanofi Corporation Information 6.5.2 Sanofi Description and Business Overview 6.5.3 Sanofi Viral Vaccines Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Sanofi Product Portfolio 6.5.5 Sanofi Recent Developments/Updates 6.6 Bayer 6.6.1 Bayer Corporation Information 6.6.2 Bayer Description and Business Overview 6.6.3 Bayer Viral Vaccines Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Bayer Product Portfolio 6.6.5 Bayer Recent Developments/Updates 6.7 Zoetis 6.6.1 Zoetis Corporation Information 6.6.2 Zoetis Description and Business Overview 6.6.3 Zoetis Viral Vaccines Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Zoetis Product Portfolio 6.7.5 Zoetis Recent Developments/Updates 6.8 AstraZeneca 6.8.1 AstraZeneca Corporation Information 6.8.2 AstraZeneca Description and Business Overview 6.8.3 AstraZeneca Viral Vaccines Sales, Revenue and Gross Margin (2016-2021) 6.8.4 AstraZeneca Product Portfolio 6.8.5 AstraZeneca Recent Developments/Updates 6.9 Johnson 6.9.1 Johnson Corporation Information 6.9.2 Johnson Description and Business Overview 6.9.3 Johnson Viral Vaccines Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Johnson Product Portfolio 6.9.5 Johnson Recent Developments/Updates 6.10 CSL 6.10.1 CSL Corporation Information 6.10.2 CSL Description and Business Overview 6.10.3 CSL Viral Vaccines Sales, Revenue and Gross Margin (2016-2021) 6.10.4 CSL Product Portfolio 6.10.5 CSL Recent Developments/Updates 7 Viral Vaccines Manufacturing Cost Analysis 7.1 Viral Vaccines Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Viral Vaccines 7.4 Viral Vaccines Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Viral Vaccines Distributors List 8.3 Viral Vaccines Customers 9 Viral Vaccines Market Dynamics 9.1 Viral Vaccines Industry Trends 9.2 Viral Vaccines Growth Drivers 9.3 Viral Vaccines Market Challenges 9.4 Viral Vaccines Market Restraints 10 Global Market Forecast 10.1 Viral Vaccines Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Viral Vaccines by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Viral Vaccines by Type (2022-2027) 10.2 Viral Vaccines Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Viral Vaccines by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Viral Vaccines by Application (2022-2027) 10.3 Viral Vaccines Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Viral Vaccines by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Viral Vaccines by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Viral Vaccines Sales (K MT) Growth Rate Comparison by Type (2021-2027) Table 2. Global Viral Vaccines Sales (K MT) Comparison by Application (2021-2027) Table 3. Global Viral Vaccines Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Viral Vaccines Covered in This Study Table 5. Global Viral Vaccines Sales (K MT) of Key Manufacturers (2016-2021) Table 6. Global Viral Vaccines Sales Share by Manufacturers (2016-2021) Table 7. Global Viral Vaccines Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Viral Vaccines Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Viral Vaccines Average Price (USD/MT) of Key Manufacturers (2016-2021) Table 10. Manufacturers Viral Vaccines Manufacturing Sites and Area Served Table 11. Manufacturers Viral Vaccines Product Type Table 12. Global Viral Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Viral Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vaccines as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Viral Vaccines Sales by Region (2016-2021) & (K MT) Table 16. Global Viral Vaccines Sales Market Share by Region (2016-2021) Table 17. Global Viral Vaccines Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Viral Vaccines Sales by Country (2016-2021) & (K MT) Table 19. North America Viral Vaccines Sales Market Share by Country (2016-2021) Table 20. North America Viral Vaccines Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Viral Vaccines Revenue Market Share by Country (2016-2021) Table 22. Europe Viral Vaccines Sales by Country (2016-2021) & (K MT) Table 23. Europe Viral Vaccines Sales Market Share by Country (2016-2021) Table 24. Europe Viral Vaccines Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Viral Vaccines Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Viral Vaccines Sales by Region (2016-2021) & (K MT) Table 27. Asia Pacific Viral Vaccines Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Viral Vaccines Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Viral Vaccines Revenue Market Share by Region (2016-2021) Table 30. Latin America Viral Vaccines Sales by Country (2016-2021) & (K MT) Table 31. Latin America Viral Vaccines Sales Market Share by Country (2016-2021) Table 32. Latin America Viral Vaccines Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Viral Vaccines Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Viral Vaccines Sales by Country (2016-2021) & (K MT) Table 35. Middle East and Africa Viral Vaccines Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Viral Vaccines Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Viral Vaccines Revenue Market Share by Country (2016-2021) Table 38. Global Viral Vaccines Sales (K MT) by Type (2016-2021) Table 39. Global Viral Vaccines Sales Market Share by Type (2016-2021) Table 40. Global Viral Vaccines Revenue (Million US$) by Type (2016-2021) Table 41. Global Viral Vaccines Revenue Share by Type (2016-2021) Table 42. Global Viral Vaccines Price (USD/MT) by Type (2016-2021) Table 43. Global Viral Vaccines Sales (K MT) by Application (2016-2021) Table 44. Global Viral Vaccines Sales Market Share by Application (2016-2021) Table 45. Global Viral Vaccines Revenue (Million US$) by Application (2016-2021) Table 46. Global Viral Vaccines Revenue Share by Application (2016-2021) Table 47. Global Viral Vaccines Price (USD/MT) by Application (2016-2021) Table 48. GSK Corporation Information Table 49. GSK Description and Business Overview Table 50. GSK Viral Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 51. GSK Viral Vaccines Product Table 52. GSK Recent Developments/Updates Table 53. Merck Corporation Information Table 54. Merck Description and Business Overview Table 55. Merck Viral Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 56. Merck Viral Vaccines Product Table 57. Merck Recent Developments/Updates Table 58. Novartis Corporation Information Table 59. Novartis Description and Business Overview Table 60. Novartis Viral Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 61. Novartis Viral Vaccines Product Table 62. Novartis Recent Developments/Updates Table 63. Pfizer Corporation Information Table 64. Pfizer Description and Business Overview Table 65. Pfizer Viral Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 66. Pfizer Viral Vaccines Product Table 67. Pfizer Recent Developments/Updates Table 68. Sanofi Corporation Information Table 69. Sanofi Description and Business Overview Table 70. Sanofi Viral Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 71. Sanofi Viral Vaccines Product Table 72. Sanofi Recent Developments/Updates Table 73. Bayer Corporation Information Table 74. Bayer Description and Business Overview Table 75. Bayer Viral Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 76. Bayer Viral Vaccines Product Table 77. Bayer Recent Developments/Updates Table 78. Zoetis Corporation Information Table 79. Zoetis Description and Business Overview Table 80. Zoetis Viral Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 81. Zoetis Viral Vaccines Product Table 82. Zoetis Recent Developments/Updates Table 83. AstraZeneca Corporation Information Table 84. AstraZeneca Description and Business Overview Table 85. AstraZeneca Viral Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 86. AstraZeneca Viral Vaccines Product Table 87. AstraZeneca Recent Developments/Updates Table 88. Johnson Corporation Information Table 89. Johnson Description and Business Overview Table 90. Johnson Viral Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 91. Johnson Viral Vaccines Product Table 92. Johnson Recent Developments/Updates Table 93. CSL Corporation Information Table 94. CSL Description and Business Overview Table 95. CSL Viral Vaccines Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 96. CSL Viral Vaccines Product Table 97. CSL Recent Developments/Updates Table 98. Production Base and Market Concentration Rate of Raw Material Table 99. Key Suppliers of Raw Materials Table 100. Viral Vaccines Distributors List Table 101. Viral Vaccines Customers List Table 102. Viral Vaccines Market Trends Table 103. Viral Vaccines Growth Drivers Table 104. Viral Vaccines Market Restraints Table 105. Global Viral Vaccines Sales Forecast by Type (2022-2027) & (K MT) Table 106. Global Viral Vaccines Sales Market Share Forecast by Type (2022-2027) Table 107. Global Viral Vaccines Revenue Forecast by Type (2022-2027) & (US$ Million) Table 108. Global Viral Vaccines Revenue Market Share Forecast by Type (2022-2027) Table 109. Global Viral Vaccines Sales Forecast by Application (2022-2027) & (K MT) Table 110. Global Viral Vaccines Sales Market Share Forecast by Application (2022-2027) Table 111. Global Viral Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million) Table 112. Global Viral Vaccines Revenue Market Share Forecast by Application (2022-2027) Table 113. Global Viral Vaccines Sales Forecast by Region (2022-2027) & (K MT) Table 114. Global Viral Vaccines Sales Market Share Forecast by Region (2022-2027) Table 115. Global Viral Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million) Table 116. Global Viral Vaccines Revenue Market Share Forecast by Region (2022-2027) Table 117. Research Programs/Design for This Report Table 118. Key Data Information from Secondary Sources Table 119. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Viral Vaccines Figure 2. Global Viral Vaccines Market Share by Type in 2020 & 2027 Figure 3. Attenuated Vaccine Product Picture Figure 4. Inactivated Vaccine Product Picture Figure 5. Global Viral Vaccines Market Share by Application in 2020 & 2027 Figure 6. Hospital Figure 7. Pharmaceutical Factory Figure 8. Research Institute Figure 9. Others Figure 10. Global Viral Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Viral Vaccines Market Size 2016-2027 (US$ Million) Figure 12. Global Viral Vaccines Sales 2016-2027 (K MT) Figure 13. Global Viral Vaccines Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 14. Viral Vaccines Sales Share by Manufacturers in 2020 Figure 15. Global Viral Vaccines Revenue Share by Manufacturers in 2020 Figure 16. The Global 5 and 10 Largest Viral Vaccines Players: Market Share by Revenue in 2020 Figure 17. Viral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 18. Global Viral Vaccines Sales Market Share by Region (2016-2021) Figure 19. Global Viral Vaccines Sales Market Share by Region in 2020 Figure 20. Global Viral Vaccines Revenue Market Share by Region (2016-2021) Figure 21. Global Viral Vaccines Revenue Market Share by Region in 2020 Figure 22. U.S. Viral Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Canada Viral Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Germany Viral Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. France Viral Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. U.K. Viral Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Italy Viral Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Russia Viral Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. China Viral Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Japan Viral Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. South Korea Viral Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. India Viral Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Australia Viral Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Taiwan Viral Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Indonesia Viral Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Thailand Viral Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Malaysia Viral Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Philippines Viral Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Vietnam Viral Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Mexico Viral Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Brazil Viral Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Argentina Viral Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Turkey Viral Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Saudi Arabia Viral Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. UAE Viral Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Sales Market Share of Viral Vaccines by Type (2016-2021) Figure 47. Sales Market Share of Viral Vaccines by Application (2016-2021) Figure 48. Sales Market Share of Viral Vaccines by Application in 2020 Figure 49. Revenue Share of Viral Vaccines by Application (2016-2021) Figure 50. Revenue Share of Viral Vaccines by Application in 2020 Figure 51. Manufacturing Cost Structure of Viral Vaccines Figure 52. Manufacturing Process Analysis of Viral Vaccines Figure 53. Viral Vaccines Industrial Chain Analysis Figure 54. Channels of Distribution Figure 55. Distributors Profiles Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

GSK Merck Novartis Pfizer Sanofi Bayer Zoetis AstraZeneca Johnson CSL